NANJING KING-FRIEND FDA Approval ANDA 214856

ANDA 214856

NANJING KING-FRIEND

FDA Drug Application

Application #214856

Application Sponsors

ANDA 214856NANJING KING-FRIEND

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAVENOUS, SUBCUTANEOUS300MG/3ML (100MG/ML)0ENOXAPARIN SODIUMENOXAPARIN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2022-06-14STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

NANJING KING-FRIEND
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214856
            [companyName] => NANJING KING-FRIEND
            [docInserts] => ["",""]
            [products] => [{"drugName":"ENOXAPARIN SODIUM","activeIngredients":"ENOXAPARIN SODIUM","strength":"300MG\/3ML (100MG\/ML)","dosageForm":"INJECTABLE;INTRAVENOUS, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/14\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-14
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.